BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 381220)

  • 21. Pirbuterol vs. hydroxyzine vs. theophylline vs. placebo in the treatment of bronchial asthma.
    Brandon ML
    Ann Allergy; 1980 Jul; 45(1):8-12. PubMed ID: 7406244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyrbuterol: a new bronchodilator. Phase I-single dose study.
    Steen SN; Ziment I; Thomas JS
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1077-81. PubMed ID: 4215618
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparative study between procaterol and salbutamol in mild to moderate bronchial asthma].
    Legris C; Boulet LP; Lafrance L; Bélanger J; Beaupré A
    Therapie; 1987; 42(2):213-6. PubMed ID: 2956725
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of oral salbutamol and pirbuterol on FEV1, heart rate and blood pressure in asthmatics.
    Willey RF; Grant IW; Pocock SJ
    Br J Clin Pharmacol; 1976 Aug; 3(4):595-600. PubMed ID: 22216500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A new aerosol adrenergic bronchodilator, procaterol. Comparative study of salbutamol and procaterol].
    Morin D; Milot J; Turcotte H; Boulet LP
    Union Med Can; 1987 Apr; 116(4):215-8. PubMed ID: 2885957
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy and safety of single therapeutic and supratherapeutic doses of indacaterol versus salmeterol and salbutamol in patients with asthma.
    Brookman LJ; Knowles LJ; Barbier M; Elharrar B; Fuhr R; Pascoe S
    Curr Med Res Opin; 2007 Dec; 23(12):3113-22. PubMed ID: 17999782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative study of carbuterol and salbutamol from metered aerosols in bronchial asthma.
    Beumer HM; Mills JG; Sharpe PC
    Respiration; 1978; 35(4):220-3. PubMed ID: 345380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of bronchodilator responses of levosalbutamol and salbutamol given via a pressurized metered dose inhaler: a randomized, double blind, single-dose, crossover study.
    Jantikar A; Brashier B; Maganji M; Raghupathy A; Mahadik P; Gokhale P; Gogtay J; Salvi S
    Respir Med; 2007 Apr; 101(4):845-9. PubMed ID: 17276051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the bronchodilator effects of broxaterol and salbutamol.
    Casali L; Rossi A; Manazza P; Colombo ML; Zoia MC
    Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):93-7. PubMed ID: 2900816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction between proxyphylline and salbutamol.
    Kanto J; Allonen H; Kulmala T; Mäntylä R; Tala E
    Int J Clin Pharmacol Ther Toxicol; 1981 Aug; 19(8):346-9. PubMed ID: 7030976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacy, as modified by the circadian rhythm of salbutamol administered by different routes.
    Lahdensuo A; Alanko K
    Scand J Respir Dis; 1976; 57(5):231-8. PubMed ID: 792993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative effects of pirbuterol acetate, metaproterenol, and placebo aerosols on pulmonary function and incidence of cardiac ectopy.
    Chodosh S; Crooks LA; Tuck J
    J Asthma; 1989; 26(5):309-15. PubMed ID: 2484663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical equivalence of a novel multiple dose powder inhaler versus a conventional metered dose inhaler on bronchodilating effects of salbutamol.
    Vidgren M; Silvasti M; Korhonen P; Kinkelin A; Frischer B; Stern K
    Arzneimittelforschung; 1995 Jan; 45(1):44-7. PubMed ID: 7893268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maximum bronchodilator effect of pirbuterol and procaterol administered as sprays with and without an aerochamber.
    Solé D; Villalba SR; Sestelo MR; Scalabrin DM; Soares FJ; Naspitz CK
    Rev Paul Med; 1993; 111(3):397-402. PubMed ID: 8108632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formoterol and salbutamol metered aerosols: comparison of a new and an established beta-2-agonist for their bronchodilating efficacy in the treatment of childhood bronchial asthma.
    von Berg A; Berdel D
    Pediatr Pulmonol; 1989; 7(2):89-93. PubMed ID: 2797925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term oral bronchodilator therapy of asthma with pirbuterol.
    Burki NK; Diamond L
    Clin Pharmacol Ther; 1978 Jul; 24(1):84-9. PubMed ID: 657723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Inhalation therapy with selective beta 2-sympathomimetic drugs. Effect of pirbuterol administered via the Autohaler and salbutamol administered via the Diskhaler in obstructive respiratory tract disease].
    Hoffarth HP; Freyberger H; Völkl KP; Ulmer WT
    Fortschr Med; 1990 Mar; 108(8):162-4. PubMed ID: 2186991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pirbuterol. A preliminary review of its pharmacological properties and therapeutic efficacy in reversible bronchospastic disease.
    Richards DM; Brogden RN
    Drugs; 1985 Jul; 30(1):6-21. PubMed ID: 2863125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of albuterol and isoproterenol aerosols in bronchial asthma.
    Jenkinson SG; Light RW; George RB
    Ann Allergy; 1977 Dec; 39(6):423-5. PubMed ID: 339788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Terbutaline: an effective bronchodilator by inhalation.
    Goldgraber MB
    Ann Allergy; 1977 Feb; 38(2):127-8. PubMed ID: 320914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.